ENDOMETRIAL METAPLASIAS, HYPERPLASIAS, ADENOCARCINOMAS
PROGNOSTIC FEATURES OF ENDOMETRIAL ADENOCARCINOMAS
Slide 18
FACTOR
FEATURE
PROGNOSIS
p53
overexpression
Present
Poorer prognosis
Her-2
/neu expression
Present
Poorer prognosis
EGF receptor expression
Present
Poorer prognosis
Aneuploidy
Present
Poorer prognosis
Cell proliferation
High S phase
Poorer prognosis